Literature DB >> 22709691

Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM.

Takeshi Isoda1, Masatoshi Takagi, Jinhua Piao, Shun Nakagama, Masaki Sato, Kyoko Masuda, Tomokatsu Ikawa, Miyuki Azuma, Tomohiro Morio, Hiroshi Kawamoto, Shuki Mizutani.   

Abstract

Immune defect in ataxia telangiectasia patients has been attributed to either the failure of V(D)J recombination or class-switch recombination, and the chromosomal translocation in their lymphoma often involves the TCR gene. The ATM-deficient mouse exhibits fewer CD4 and CD8 single-positive T cells because of a failure to develop from the CD4(+)CD8(+) double-positive phase to the single-positive phase. Although the occurrence of chromosome 14 translocations involving TCR-δ gene in ATM-deficient lymphomas suggests that these are early events in T-cell development, a thorough analysis focusing on early T-cell development has never been performed. Here we demonstrate that ATM-deficient mouse thymocytes are perturbed in passing through the β- or γδ-selection checkpoint, leading in part to the developmental failure of T cells. Detailed karyotype analysis using the in vitro thymocyte development system revealed that RAG-mediated TCR-α/δ locus breaks occur and are left unrepaired during the troublesome β- or γδ-selection checkpoints. By getting through these selection checkpoints, some of the clones with random or nonrandom chromosomal translocations involving TCR-α/δ locus are selected and accumulate. Thus, our study visualized the first step of multistep evolutions toward lymphomagenesis in ATM-deficient thymocytes associated with T-lymphopenia and immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22709691     DOI: 10.1182/blood-2012-02-413195

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

2.  Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Authors:  Matan Kraus; Atar Lev; Amos J Simon; Inbal Levran; Andrea Nissenkorn; Yonit B Levi; Yackov Berkun; Ori Efrati; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

Review 3.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

4.  Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity.

Authors:  Ryan H Newton; Yu Lu; Antonella Papa; Greg H Whitcher; Youn-Jung Kang; Catherine Yan; Pier Paolo Pandolfi; Laurence A Turka
Journal:  Blood       Date:  2014-12-04       Impact factor: 22.113

5.  Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Amy DeMicco; Craig H Bassing
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

Review 8.  XCIND as a genetic disease of X-irradiation hypersensitivity and cancer susceptibility.

Authors:  Shuki Mizutani; Masatoshi Takagi
Journal:  Int J Hematol       Date:  2012-12-25       Impact factor: 2.490

9.  Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.

Authors:  Masafumi Seki; Shunsuke Kimura; Tomoya Isobe; Kenichi Yoshida; Hiroo Ueno; Yaeko Nakajima-Takagi; Changshan Wang; Lin Lin; Ayana Kon; Hiromichi Suzuki; Yusuke Shiozawa; Keisuke Kataoka; Yoichi Fujii; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Teppei Shimamura; Kyoko Masuda; Hiroshi Kawamoto; Kentaro Ohki; Motohiro Kato; Yuki Arakawa; Katsuyoshi Koh; Ryoji Hanada; Hiroshi Moritake; Masaharu Akiyama; Ryoji Kobayashi; Takao Deguchi; Yoshiko Hashii; Toshihiko Imamura; Atsushi Sato; Nobutaka Kiyokawa; Akira Oka; Yasuhide Hayashi; Masatoshi Takagi; Atsushi Manabe; Akira Ohara; Keizo Horibe; Masashi Sanada; Atsushi Iwama; Hiroyuki Mano; Satoru Miyano; Seishi Ogawa; Junko Takita
Journal:  Nat Genet       Date:  2017-07-03       Impact factor: 38.330

10.  Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.

Authors:  Zhen Yang; Yi Shen; Hisashi Oishi; Eric L Matteson; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2016-03-23       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.